Bioceres Crop Solutions Corp. BIOX
Set alert
0.22 USD +0.01 +3.16%
At close · Nov 2
0.23 0.00 +1.98%
After hours · Nov 2, 4:00 PM ET
0.2053 Day range 0.23
0.19 52-week range 2.03
- YTD
- -83.08%
- 1 year
- -89.08%
- Open
- 0.2149
- Prev close
- 0.2149
- Mkt cap
- 14.15M
- Vol
- 432.16K
- Avg vol
- 316.74K
- EPS
- -1.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2053
- High
- 0.23
- Forward P/E
- 9.88
- Beta
- 0.47
- Short ratio
- 3.12
- Inst. own
- 23.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 6.74
- 200-d avg
- 9.83
- 1y target
- 12.13
YTD chart
Signals (33)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 2026 | 3 days ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 9, 2026 | 3 months ago |
| RSI: Oversold | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
Newest 20 of 33.
Analyst view
Consensus: none
Price target (mean) 12.13 +5369.1% upside
Now 0.2217
- Target (low)
- 9.50
- Target (mean)
- 12.13
- Target (high)
- 13.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.15 | 0.11 – 0.20 | 0.00156 | +9515.4% | 144.63M | +3.1% | 3 |
| Next quarter | -0.03 | -0.08 – 0.02 | 0.139 | -121.6% | 83.45M | -0.6% | 3 |
| Current year | 0.28 | 0.16 – 0.43 | 0.0502 | +457.8% | 463.43M | -0.3% | 3 |
| Next year | 0.535 | 0.46 – 0.61 | 0.28 | +91.1% | 510.63M | +10.2% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 21, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 17, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 11, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 11, 2024 | Roth MKM | Maintained | Buy | Buy |
| Sep 11, 2024 | Lake Street | Maintained | Buy | Buy |
| Sep 11, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 9, 2024 | Roth MKM | Maintained | Buy | Buy |
| Nov 1, 2023 | Roth MKM | Maintained | Buy | Buy |
| Sep 12, 2023 | Lake Street | Maintained | Buy | Buy |
| Sep 12, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Aug 16, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Apr 6, 2023 | Oppenheimer | Initiated | — | Outperform |
| Sep 30, 2022 | Canaccord Genuity | Initiated | — | Buy |
| Oct 8, 2021 | Roth Capital | Initiated | — | Buy |
| Mar 15, 2021 | Lake Street | Initiated | — | Buy |